Insmed Incorporated - Income Statement (TTM)

Insmed Incorporated
MX ˙ BMV ˙ US4576693075
Income Statement (TTM)

Insmed Incorporated Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 169 164 168 171 174 188 201 221 242 245 257 269 281 305 315 329 343 364 381 398
Change (%) -2.54 2.04 1.71 1.82 8.47 6.84 9.86 9.48 1.31 4.93 4.66 4.21 8.69 3.37 4.16 4.37 6.05 4.76 4.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 94 40 27 42 42 44 46 52 55 55 57 57 60 66 69 74 78 86 90 97
Change (%) -57.54 -33.41 58.82 -1.04 5.81 5.32 11.95 6.32 -0.40 2.97 0.35 5.68 8.93 5.53 6.32 6.07 9.88 4.46 7.94
% of Revenue 55.66 24.25 15.82 24.71 24.01 23.43 23.09 23.53 22.85 22.47 22.05 21.14 21.44 21.48 21.93 22.39 22.75 23.57 23.51 24.28
Gross Operating Profit 75 125 141 128 132 144 155 169 187 190 201 213 221 240 246 255 265 278 291 301
Change (%) 66.48 13.39 -9.03 2.77 9.30 7.31 9.23 10.46 1.82 5.50 5.88 3.81 8.62 2.78 3.55 3.88 4.92 4.86 3.42
% of Revenue 44.34 75.75 84.18 75.29 75.99 76.57 76.91 76.47 77.15 77.53 77.95 78.86 78.56 78.52 78.07 77.61 77.25 76.43 76.49 75.72
SG&A 198 204 204 211 225 234 239 242 257 266 289 313 328 345 358 380 408 461 516 564
Change (%) 2.94 0.10 3.69 6.48 3.84 2.22 1.17 6.33 3.43 8.72 8.46 4.80 4.89 3.83 6.19 7.45 12.98 11.81 9.35
% of Revenue 117.25 123.84 121.49 123.85 129.51 123.99 118.63 109.25 106.11 108.32 112.23 116.30 116.96 112.87 113.37 115.59 119.00 126.78 135.31 141.61
R&D 90 181 221 235 264 273 296 320 349 398 441 549 559 571 564 514 556 598 630 660
Change (%) 101.75 22.04 6.41 12.30 3.23 8.42 8.07 9.24 13.87 10.95 24.59 1.69 2.20 -1.19 -8.90 8.11 7.68 5.26 4.83
% of Revenue 53.22 110.18 131.79 137.88 152.06 144.72 146.86 144.47 144.15 162.02 171.30 203.91 198.97 187.09 178.84 156.42 162.02 164.52 165.30 165.86
OpEx 386 430 456 494 536 556 586 618 666 723 792 925 952 986 996 972 1,047 1,150 1,240 1,326
Change (%) 11.17 6.24 8.18 8.55 3.66 5.49 5.50 7.78 8.55 9.44 16.81 2.98 3.54 1.02 -2.38 7.65 9.88 7.80 6.91
% of Revenue 229.09 261.32 272.09 289.38 308.49 294.82 291.10 279.54 275.20 294.87 307.54 343.22 339.17 323.10 315.75 295.93 305.25 316.26 325.44 333.02
Operating Income -218 -265 -289 -323 -362 -367 -385 -397 -424 -478 -534 -655 -672 -681 -681 -644 -704 -787 -859 -928
Change (%) 21.79 8.85 11.93 12.10 1.35 4.80 3.22 6.83 12.69 11.76 22.66 2.47 1.38 -0.04 -5.41 9.33 11.74 9.21 7.99
% of Revenue -129.09 -161.32 -172.09 -189.38 -208.49 -194.82 -191.10 -179.54 -175.20 -194.87 -207.54 -243.22 -239.17 -223.10 -215.75 -195.93 -205.25 -216.26 -225.44 -233.02
Interest Expense -29 -30 -30 -33 -37 -40 -36 -29 -21 -28 -46 -62 -81 -81 -79 -80 -83 -85 -88 -88
Change (%) 0.51 0.50 9.59 12.47 10.52 -10.55 -19.23 -26.99 31.01 65.23 34.79 29.27 1.05 -3.51 1.84 4.15 2.24 3.39 0.41
% of Revenue -17.43 -17.98 -17.71 -19.08 -21.08 -21.48 -17.98 -13.22 -8.82 -11.40 -17.95 -23.12 -28.68 -26.66 -24.89 -24.33 -24.28 -23.41 -23.11 -22.21
Net Income -245 -294 -319 -375 -424 -435 -438 -416 -434 -482 -547 -696 -724 -750 -747 -803 -864 -914 -1,013 -1,034
Change (%) 20.10 8.59 17.37 13.09 2.54 0.69 -4.95 4.43 10.85 13.53 27.29 3.99 3.58 -0.36 7.47 7.67 5.73 10.89 2.08
% of Revenue -145.14 -178.87 -190.36 -219.67 -243.96 -230.63 -217.35 -188.04 -179.36 -196.26 -212.33 -258.22 -257.69 -245.59 -236.74 -244.27 -252.01 -251.24 -265.93 -259.82

Source: Capital IQ

Other Listings
DE:IM8N €124.00
US:INSM $147.20
GB:0JAV $147.74
IT:1INSM €122.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista